Nominee for FDA Commissioner Has Pharma Industry Ties
If confirmed by Congress, the next commissioner of the U.S. Food and Drug Administration (FDA) will be Robert M. Califf, MD. Dr. Califf is currently the FDA’s deputy commissioner for Medical Products and Tobacco—a position to which he was appointed on January 26, 2015, just two months prior to the end of former FDA commissioner Margaret Hamburg’s six-year term.
Does Pharma Pressure Sway FDA Drug Approvals?
For patients and physicians, the common belief is that all drugs undergo the same rigorous review, but the truth is, the Food and Drug Administration (FDA), which stands as the gatekeeper for the sanction of drug and device products, has flexible standards on what they approve and do not approve. Unknowingly to the public, the federal agency approves drugs based on…
Pharma-Government Conflicts of Interest Exposed
Conflicts of interest are rampant and easily made public in doctor-pharmaceutical relationships, however, they stay a little more hidden for industry and federal agencies. While it is inevitable that big pharma be present in public health agencies as individual leaders bounce from organization to organization—meanwhile maintaining past relationships, roles and…